Centessa Pharmaceuticals plc

CNTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$383,221$128,030$393,644$595,082
Short-Term Investments$98,956$128,519$0$0
Receivables$45,296$39,148$26,723$16,814
Inventory$0$0$0$0
Other Curr. Assets$8,936$19,395$17,380$16,878
Total Curr. Assets$536,409$315,092$437,747$628,774
Property Plant & Equip (Net)$11,757$12,953$1,168$162
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$26,586$29,647$3,512$0
Other NC Assets$2,046$2,554$1,880$699
Total NC Assets$40,389$45,154$6,560$861
Other Assets$0$0$0$0
Total Assets$576,798$360,246$444,307$629,635
Liabilities
Payables$7,143$11,815$13,836$8,065
Short-Term Debt$0$0$0$0
Tax Payable$835$112$1,582$769
Deferred Revenue$0$0$0$0
Other Curr. Liab.$50,020$27,458$22,920$15,804
Total Curr. Liab.$57,998$39,385$38,338$24,638
LT Debt$117,226$84,588$69,800$75,700
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$29$29$0$37,743
Total NC Liab.$117,255$84,617$69,800$113,443
Other Liabilities$0$0$0$0
Cap. Leases$8,286$8,888$0$0
Total Liabilities$175,253$124,002$108,138$138,081
Equity
Pref Stock$0$0$0$0
Common Stock$359$273$265$252
Retained Earnings-$988,702-$752,945-$601,860-$385,653
AOCI$4,213$1,493-$1,497$688
Other Equity$1,385,675$987,423$939,261$876,267
Total Equity$401,545$236,244$336,169$491,554
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$576,798$360,246$444,307$629,635
Net Debt-$265,995-$43,442-$323,844-$519,382